Zusammenfassung
Prionkrankheiten sind übertragbare neurodegenerative Krankheiten, die bei Mensch und Tier auftreten (Prusiner 1998) (Tabellen 11.1–11.3). Klinisch gehen sie mit einer meist stark ausgeprägten Demenz und verschiedenen neurologischen Veränderungen wie Ataxie, Myoklonien oder Erblindung einher; sie nehmen immer einen tödlichen Verlauf.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Anderson R M, Donnelly C A, Ferguson N M et al. (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature 382: 779–788
Baker H F, Duchen L W, Jakobs J M, Ridley R M (1991) Spongiform encephalopathy transmitted experimentally from Creutzfeldt-Jakob and familial Gerstmann-Sträussler-Scheinker disease. Brain 113: 1891
Baringer J R, Bowman K A, Prusiner S B (1983) Replication of the scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol 42: 539–547
Beekes M, Baldauf E, Diringer H (1996) Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol 77: 1925–1934
Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek D C, Gibbs C J Jr (1977) Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1: 478–479
Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar HA (2000) Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning of intesely fluorescent targets. Proc Natl Acad Sci USA 97: 5468–5473
Boellaard J W, Brown P, Tateishi J (1999) Gerstmann-Sträussler-Scheinker disease—the dilemma of molecular and clinical correlations. Clin Neuropathol 18: 271–285
Brandner S, Isenmann S, Raeber A et al. (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379: 339–343
Brown P (1996) Environmental causes of human spongiform encephalopathy. In: Baker H F, Ridley R M (eds) Prion diseases. Humana, Totowa/NJ, pp 139–154
Brown P, Preece M A, Will R G (1992) Friendly fire in medicine. Hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340: 24–27
Brown P, Wolff A, Gajdusek D C (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40: 887–890
Bruce M E (1985) Agent replication dynamics in a long incubation period model of mouse scrapie. J Gen Virol 66: 2517–2522
Bruce M E, Will R G, Ironside J W et al. (1997) Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 389: 489–501
Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339–1348
Bundza A, Charlton K M (1988) Comparison of spongiform lesions in experimental scrapie and rabies in skunks. Acta Neuropathol 76: 275–280
Caughey B, Raymond G J (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease-sensitive and phospholipase-sensitive. J Biol Chem 266: 18217–18223
Chabry J, Priola S A, Wehrly K, Nishio J, Hope J, Chesebro B (1999) Species-independent inhibition of abnormal prion protein ( PrP) formation by a peptide containing a conserved PrP sequence. J Virol 73: 6245–6250
Cochius J I, Mack K, Burns R J, Alderman CP, Blumbergs P C (1990) Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. Aust NZ J Med 20: 592–593
Collinge J, Owen F, Poulter M et al. (1990) Prion dementia without characteristic pathology. Lancet 336: 7–9
Collinge J, Brown J, Hardy J, (1992) Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115: 687–710
Collinge J, Sidle K C L, Meads J, Ironside J, Hill A F (1996) Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383: 685–690
Cousens S N, Vynnycky E, Zeidler M, Will R G, Smith P G (1997) Predicting the CJD epidemic in humans. Nature 385: 197–198
Creutzfeldt H G (1920) Über eine eigenartige herdförmige Erkrankung des Zentralnervensystems. Z Ges Neurol Psychiatr 57: 1–18
Cuillé J, Chelle P-L (1936) La maladie dite tremblante du mouton estelle inoculable? C R Acad Sci (III) 203: 1552–1554
David-Ferreira J F, David-Ferreira K L, Gibbs C J Jr, Morris J A (1968) Scrapie in mice: ultrastructural observations in the cerebral cortex. Proc Soc Exp Biol Med 127: 313–320
Doi-Yi R, Kitamoto T, Tateishi J (1991) Immunoreactivity of cerebral amyloidosis is enhanced by protein denaturation treatments. Acta Neuropathol 82: 260–265
Duffy P, Wolf J, Collins G, DeVoe A G, Streeten B, Cowen D (1974) Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290: 692–693
Eigen M (1996) Prionics or the kinetic basis of prion diseases. Biophys Chem 63: A1–A18
Esmonde T, Lueck C J, Symon L, Duchen L W, Will R G (1993) Creutzfeldt-Jakob disease and lyophilised dura mater grafts - report of 2 cases. J Neurol Neurosurg Psychiatry 56: 999–1000
Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362: 543–546
Fradkin J E, Schönberger L B, Mills J L et al. (1991) Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United State. JAMA 265: 880–884
Frasier S D, Foley T P (1994) Clinical review 58. Creutzfeldt- Jakob disease in recipients of pituitary hormones. J Clin Endocrin Metabol 78: 1277–1279
Gabizon R, Rosenmann H, Meiner Z, Kahana I, Kahana E, Shugart Y, Ott J, Prusiner S B (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease ( CJD ). Am J Hum Genet 53: 828–835
Gabriel J M, Oesch B, Kretzschmar H A, Scott M, Prusiner S B (1992) Molecular cloning of a candidate chicken prion protein. Proc Natl Acad Sci USA 89: 9097–9101
Gambetti P, Lugaresi E (1998) Conclusions of the Symposium ( FFI ). Brain Pathol 8: 571–575
Gerstmann J (1928) Über ein noch nicht beschriebenes Reflexphänomen bei einer Erkrankung des zerebellaren Systems. Wien Med Wochenschr 78: 906–908
Gerstmann J, Sträussler E, Scheinker I (1936) Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154: 736–762
Giese A, Groschup M H, Hess B, Kretzschmar H A (1995) Neuronal cell death in scrapie infected mice is due to apoptosis. Brain Pathol 5: 213–221
Giese A, Brown D R, Groschup M, Feldmann C, Haist I, Kretzschmar H A (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8: 449–457
Goldfarb L G, Brown P, Goldgaber D, (1989) Patients with Creutzfeldt-Jakob disease and kuru lack the mutation in the PRIP gene found in Gerstmann-Sträussler syndrome, but they show a different double allele mutation in the same gene. Am J Hum Genet 45 (Suppl): A189–A189 (Abstract)
Goldfarb L G, Mitrovä E, Brown P, Toh B H, Gajdusek D C (1990a) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336: 514–515
Goldfarb L G, Korczyn A D, Brown P, Chapman J, Gajdusek D C (1990b) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336: 637–638
Goldfarb L G, Brown P, Mitrowa E et al. (1991a) Creutzfeldt- Jakob disease associated with the PRNP codon 200 Lys mutation. An analysis of 45 families. Eur J Epidemiol 7: 477–486
Goldfarb L G, Brown P, McCombie W R et al. (1991b) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88: 10926–10930
Goldfarb L G, Petersen R B, Tabaton M et al. (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806–808
Goldmann W, Hunter N, Foster J D, Salbaum J M, Beyreuther K, Hope J (1990) Two alleles of a neural protein linked to scrapie in sheep. Proc Natl Acad Sci USA 87: 2476–2480
Goldmann W, Hunter N, Martin T, Dawson M, Hope J (1991) Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol 72: 201–204
Hadlow W J (1959) Scrapie and kuru. Lancet 2: 289–290
Hainfellner J A, Liberski P P, Guiroy D C, Cervenakova L, Brown P, Gajdusek D C, Budka H (1997) Pathology and immunocytochemistry of a Kuru Brain. Brain Pathol 7: 547–553
Hegde R S, Tremblay P, Groth D, DeArmond S J, Prusiner S B, Lingappa V R (1999) Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402: 822–826
Hilton D A, Fathers E, Edwards P, Ironside J W, Zajicek J (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352: 703–704
Hsiao K, Baker H F, Crow T J et al. (1989) Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338: 342–345
Hsiao K, Scott M, Foster D, Groth D F, DeArmond S J, Prusiner S B (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587–1590
Hsiao K, Groth D, Scott M et al. (1994) Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci USA 91: 9126–9130
Jakob A (1921) Über eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswertem anatomischem Befunde (spastische Pseudosklerose-Encephalomyelopathie mit disseminierten Degenerationsherden). Dtsch Z Nervenheilkd 70: 132–146
Jakob A (1923) Spastische Pseudosklerose. In: Jakob A (ed) Die extrapyramidalen Erkrankungen. Springer, Berlin, S 215–245
Jeffrey M, Goodbrand I A, Goodsir C M (1995) Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructure. Micron 26: 277–298
Kahana E, Alter M, Braham J, Sofer D (1974) Creutzfeldt-Jakob disease: Focus among Libyan Jews in Israel. Science 183: 90–91
Kim Y S, Carp R I, Callahan S M, Wisniewski H M (1987) Incubation periods and survival times for mice injected stereotaxically with three scrapie strains in different brain regions. J Gen Virol 68: 695–702
Kimberlin R H, Walker C A (1980) Pathogenesis of mouse scrapie: evidence for neural spread of infection to the CNS. J Gen Virol 51: 183–187
Kitamoto T, Ogomori K, Tateishi J, Prusiner S B (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 57: 230–236
Kitamoto T, Shin R-W, Dohura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J (1992) Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 140: 1285–1294
Klein M A, Frigg R, Raeber A J et al. (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4: 1429–1433
Kocisko D A, Come J H, Priola S A, Chesebro B, Raymond G J, Lansbury P T, Caughey B (1994) Cell-free formation of protease-resistant prion protein. Nature 370: 471–473
Kretzschmar H A, Prusiner S B, Stowring L E, DeArmond S J (1986a) Scrapie prion proteins are synthesized in neurons. Am J Pathol 122: 1–5
Kretzschmar H A, Stowring L E, Westaway D, Stubblebine W H, Prusiner S B, DeArmond S J (1986b) Molecular cloning of a human prion protein cDNA. DNA 5: 315–324
Kretzschmar H A, Honold G, Seiteiberger F, Feucht M, Wessely P, Mehraein P, Budka H (1991) Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 337: 1160–1160
Kretzschmar H A, Neumann M, Stavrou D (1995) Codon 178 mutation of the human prion protein gene in a German family (Backer family): sequencing data from 72 year-old celloidinembedded brain tissue. Acta Neuropathol (Berl) 89: 96–98
Kretzschmar H A, Ironside J W, DeArmond S J, Tateishi J Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 53: 913–920
Kretzschmar H, Giese A, Zerr I, Windl O, Schulz-Schaeffer W, Skworc K, Poser S (1998) The German FFI cases. Brain Pathol 8: 559–561
Lane K L, Brown P, Howell D N, Crain B J, Hulette C M, Burger P C, DeArmond S J (1994) Creutzfeldt-Jakob disease in a pregnant woman with an implanted dura mater graft. Neurosurgery 34: 737–740
Lang C J G, Schüler P, Engelhardt A, Spring A, Brown P (1995) Probable Creutzfeldt-Jakob disease after a cadaveric dural graft. Eur J Epidemiol 11: 79–81
Lantos P L, Bhatia K, Al-Sarraj S, Doshi R, Beck J, Collinge J Is the neuropathology of new variant Creutzfeldt-Jakob disease and kuru similiar? Lancet 350: 187–188
Liberski P P, Budka H, Sluga E, Barcikowska M, Kwiecinski H (1991) Tubulovesicular structures in human and experimental Creutzfeldt-Jakob disease. Eur J Epidemiol 7: 551–555
Liberski P P, Yanagihara R, Wells G A H, Gibbs C J, Gajdusek D C (1992) Comparative ultrastructural neuropathology of naturally occurring bovine spongiform encephalopathy and experimentally induced scrapie and Creutzfeldt-Jakob disease. J Comp Pathol 106: 361–381
Liberski P P, Jeffrey M, Goodsir C (1997) Tubulovesicular structures are not labeled using antibodies to prion protein ( PrP) with the immunogold electron microscopy techniques. Acta Neuropathol 93: 260–264
MacDonald S T, Sutherland K, Ironside J W (1996) Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol Appi Neurobiol 22: 285–292
Marsh R F, Sipe J C, Morse S S, Hanson R P (1976) Transmissible mink encephalopathy. Reduced spongiform degeneration in aged mink of the Chediak-Higashi genotype. Lab Invest 34: 381–386
Martinez-Lage J F, Sola J, Poza M, Esteban J A (1993) Pediatric Creutzfeldt-Jakob disease - probable transmission by a dural graft. Child Nerv Sys 9: 239–242
Masters C L, Harris J O, Gajdusek D C, Gibbs C J Jr, Bernoulli C, Asher D M (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 5: 177–188
Masters C L, Gajdusek D C, Gibbs C J Jr (1981) Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome. With an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. Brain 104: 559–588
Masullo C, Pocchiari M, Macchi G, Alemä G, Piazza G, Panzera M A (1989) Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg 71: 954–955
McLean C A, Ironside J W, Alpers M P et al. (1998) Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol 8: 429–437
Medori R, Tritschler H-J, LeBlanc A et al. (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326: 444–449
Meggendorfer F (1930) Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudosklerose. Z Ges Neurol Psychiatr 128: 337–341
Miyashita K, Inuzuka T, Kondo H et al. (1991) Creutzfeldt- Jakob disease in a patient with a cadaveric dural graft. Neurology 41: 940–941
Miyazono M, Kitamoto T, Dohura K, Iwaki T, Tateishi J (1992) Creutzfeldt-Jakob disease with codon-129 polymorphism (valine). A comparative study of patients with codon-102 point mutation or without mutations. Acta Neuropathol (Beri) 84: 349–354
Mizutani T, Okumura A, Oda M, Shiraki H (1981) Panence- phalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol 44: 103–115
Monari L, Chen S G, Brown P et al. (1994) Fatal familial insomnia and familial Creutzfeldt-Jakob disease different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci USA 91: 2839–2842
Montagna P, Cortelli P, Avoni P et al. (1998) Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol 8: 520
Moser M, Colello R J, Pott U, Oesch B (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14: 509–517
Müller W E G, Ushijima H, Schroder H C et al. (1993) Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246: 261–267
Oesch B, Westaway D, Wälchli, (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735–746
Parchi P, Castellani R, Capellari S et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt- Jakob disease. Ann Neurol 39: 767–778
Parchi P, Capellari S, Chen S et al. (1997) Typing prion isoforms. Nature 386: 232–233
Parchi P, Petersen R B, Chen S G et al. (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8: 539–548
Parchi P, Giese A, Capellari S et al. (1999) Classification of sporadic Creutzfeldt-Jakob diseae based on molecular and phenotypic analysis of 300 subjects. Arch Neurol 46: 224–233
Prusiner S B (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136–144
Prusiner S B (1998) Prions. Proc Natl Acad Sci USA 95: 13363–13383
Prusiner S B, Scott M R, DeArmond S J, Cohen F E (1998) Prion protein biology - review. Cell 93: 337–348
Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49: 320–329
Race R, Oldstone M, Chesebro B (2000) Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J Virol 74: 828–833
Raymond G J, Hope J, Kocisko D A et al. (1997) Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature 388: 285–288
Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K (1996) NMR structure of the mouse prion protein domain PrP (121–231) Nature 382: 180–182
Sato T, Hoshi K, Yoshino H, Urata J, Nakamura Y, Yanagawa H (1998) Creutzfeldt-Jakob disease associated with cadaveric duramater grafts, Japan, January 1979 – May 1996. JAMA 279: 11–12
Schätzl H M, Da Costa M, Taylor L, Cohen F E, Prusiner SB Prion protein gene variation among primates. J Mol Biol 245: 362–374
Schulz-Schaeffer W J, Giese A, Windl O, Kretzschmar H A Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol 15: 353–357
Schulz-Schaeffer W J, Tschöke S, Kranefuss N et al. (2000) The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases. Am J Pathol 156: 51–56
Scott M R, Will R, Ironside J, Nguyen H O, Tremblay P, DeArmond S J, Prusiner S B (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc Natl Acad Sci USA 96: 15137–15142
Sharpe A H, Hunter J J, Chassler P, Jaenisch R (1990) Role of abortive retroviral infection of neurons in spongiform CNS degeneration. Nature 346: 6280
Stahl N, Borchelt D R, Hsiao K, Prusiner S B (1987) Scrapie prion protein contains a phospatidylinositol glycolipid. Cell 51: 229–240
Tateishi J, Ohta M, Koga M, Sato Y, Kuroiwa Y (1979) Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 5: 581–584
Telling G C, Scott M, Hsiao K et al. (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 91: 9936–9940
Telling G C, Scott M, Mastrianni J, Gabizon R et al. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83: 79–90
Telling G C, Parchi P, DeArmond S J et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274: 2079–2082
Thadani V, Penar P L, Partington J, (1988) Creutzfeldt- Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 69: 766–769
Westaway D, DeArmond S J, Cayetano-Canlas J et al. (1994a) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild type prion proteins. Cell 76: 117–129
Westaway D, Cooper C, Turner S, Da Costa M, Carlson G A, Prusiner S B (1994b) Structure and polymorphism of the mouse prion protein gene. Proc Natl Acad Sci USA 91: 6418–6495
WHO (1998) Weekly Epidemiological Record 73: 361–372
Will R G, Matthews W B (1982) Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 45: 235–238
Will R G, Ironside J W, Zeidler M et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347: 921–925
Willison H J, Gale A N, McLaughlin J E (1991) Creutzfeldt-Jakob disease following cadaveric dura mater graft. J Neurol Neurosurg Psychiatry 54: 940–940
Windl O, Kretzschmar H A (2000) Prion Diseases. Contemp Neurol (Neurogenetics) 57: 191–218
Windl O, Dempster M, Estibeiro P, Lathe R (1995) A candidate marsupial PrP gene reveals two domains conserved in mammalian PrP proteins. Gene 159: 181–186
Windl O, Giese A, Schulz-Schaeffer W et al. (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105: 244–252
Yagi H, Irino M, Matsushita T et al. (1989) Spontaneous spongy degeneration of the brain stem in SAM-P/8 mice, a newly developed memory-deficient strain. J Neuropathol Exp Neurol 48: 577–590
Yamada S, Aiba T, Endo Y, Hara M, Kitamoto T, Tateishi J (1994) Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft. Neurosurgery 34: 740–744
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kretzschmar, H.A. (2002). Prionkrankheiten (transmissible spongiforme Enzephalopathien). In: Peiffer, J., Schröder, J.M., Paulus, W. (eds) Neuropathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59371-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-59371-0_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63951-7
Online ISBN: 978-3-642-59371-0
eBook Packages: Springer Book Archive